[Lamprene (Clofazimine) treatment of chronic lupus erythematoides (author's transl)].
Lamprene (Clofazimine) was administered over a period of three months, at a dose of 100 mg to 200 mg per day, to six patients with chronic lupus erythematosus. Remission was observed in these six cases, without any side-effect.
D000328:Adult; D002908:Chronic Disease; D002991:Clofazimine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D002991:Clofazimine
Traitement du lupus érythémateux chronique par le lamprène (clofazimine) (etude préliminaire).